Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-21
SponsorSheba Medical Center
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.
None
None
Sheba Medical Center
Lead sponsor
Tel-Aviv Sourasky Medical Center
Collaborator
Maccabi Healthcare Services, Israel
Collaborator
Wolfson Medical Center
Collaborator
Assaf-Harofeh Medical Center
Collaborator